Literature DB >> 22807239

Phenotypic variability of parkin mutations in single kindred.

Brianada Koentjoro1, Jin-Sung Park, Ainhi Duy Ha, Carolyn M Sue.   

Abstract

BACKGROUND: Mutations in parkin have been associated with autosomal recessive early-onset Parkinson's disease (PD). Here, we report on unusual phenotypic variability within a family with mutations in parkin.
METHODS: The proband and her parents were clinically assessed. Mutation analysis was performed using genomic DNA and complementary DNA. The protein expression of Parkin and Mitofusin 2 was examined by western blotting.
RESULTS: The proband was a compound heterozygote with no detectable Parkin and presented with early-onset PD. The father, a single heterozygote with reduced expression of Parkin, had mild loss of arm swing. The mother, who had only very mild rigidity, was unexpectedly found to be a homozygote with no Parkin expression. The proband, but not the parents, met the Queen Square Brain Bank criteria for PD. Parkin-dependent ubiquitination of Mitofusin 2 was impaired in the mother and the proband.
CONCLUSION: We report the first case of a homozygous mutation carrier in parkin who had no functional protein and only mild signs of parkinsonism in her seventh decade, whereas her daughter developed typical early-onset PD. This family demonstrates phenotypic variability in parkin-related parkinsonism. © 2012 Movement Disorder Society.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807239     DOI: 10.1002/mds.25041

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.

Authors:  William Zhu; Xiaoping Huang; Esther Yoon; Sara Bandres-Ciga; Cornelis Blauwendraat; Kimberly J Billingsley; Joshua H Cade; Beverly P Wu; Victoria H Williams; Alice B Schindler; Janet Brooks; J Raphael Gibbs; Dena G Hernandez; Debra Ehrlich; Andrew B Singleton; Derek P Narendra
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

2.  Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.

Authors:  Brianada Koentjoro; Jin-Sung Park; Carolyn M Sue
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

3.  The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.

Authors:  Tom Cornelissen; Dominik Haddad; Fieke Wauters; Cindy Van Humbeeck; Wim Mandemakers; Brianada Koentjoro; Carolyn Sue; Kris Gevaert; Bart De Strooper; Patrik Verstreken; Wim Vandenberghe
Journal:  Hum Mol Genet       Date:  2014-05-22       Impact factor: 6.150

Review 4.  Therapeutic targeting of mitophagy in Parkinson's disease.

Authors:  Shashank Masaldan; Sylvie Callegari; Grant Dewson
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

5.  Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations.

Authors:  David Isaacs; Daniel Claassen; Aaron B Bowman; Peter Hedera
Journal:  Brain Sci       Date:  2017-06-24

6.  Commentary: Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.

Authors:  Jin-Sung Park; Brianada Koentjoro; Carolyn M Sue
Journal:  Front Mol Neurosci       Date:  2017-09-19       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.